KPMA urged to reconsider the government's drug policy

Published: 2002-04-10 07:00:00

Updated: 2002-04-10 07:00:00

The Korean Pharmaceutical Manufacturers Association (KPMA) says that the government's drug policy to adopt the lowest insurance-covered drug price will affect badly the survival of the pharmaceutical industry and collapse the distribution channel of drugs.

The government aims to reduce the dr...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK